Objectives : The association of left ventricular global longitudinal strain (LV-GLS) with clinical
outcomes in patients with hypertrophic cardiomyopathy (HCM) has been examined in …

Surgical myectomy remains the time-honored primary treatment for hypertrophic cardiomyopathy
patients with drug refractory limiting symptoms due to LV outflow obstruction. Based on …

Objectives : The goal of this study was to determine the impact of race on identification of
hypertrophic cardiomyopathy (HCM). Background : Sudden death in young competitive athletes …

Objectives : The purpose of this study was to perform a systematic review and meta-analysis
of comparative studies to compare outcomes of septal ablation (SA) with septal myectomy (…

The relationship among myocardial fibrosis, segmental strains, and hypertrophic cardiomyopathy
(HCM) in patients with preserved left ventricular ejection fraction is not known. We …

Objectives : In hypertrophic cardiomyopathy (HCM) patients undergoing surgical myectomy,
we sought to determine the association between pre-operative cardiac magnetic resonance (…

BACKGROUND: Septal myectomy is the gold-standard therapy for hypertrophic obstructive
cardiomyopathy (HOCM). However, it is being challenged by a less-invasive alternative: …

Objectives : This study was conducted to evaluate follow-up results in patients with hypertrophic
obstructive cardiomyopathy (HOCM) who underwent either percutaneous transluminal …

Background— We report the predictors of long-term outcomes of symptomatic hypertrophic
cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. …

Hypertrophic cardiomyopathy (HCM) is a complex and common genetic disease. The left
ventricular outflow tract obstruction is an important determinant of symptoms and outcomes. Its …